The Resorbable Bone Substitute industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships, such as the collaboration between Orthofix and LimaCorporate, have aimed to enhance product portfolios and expand market presence. Furthermore, the industry has seen strategic mergers and acquisitions, including the acquisition of BioHorizons by Henry Schein, which has led to increased consolidation and competition. Recently, there have been several product launches, such as the introduction of new resorbable bone graft substitutes, which offer improved osteogenic properties and biocompatibility. These advancements have been supported by regulatory changes, with the FDA clearing new products for market entry, and a shift in consumer trends towards more minimally invasive and biodegradable solutions. These developments have been fueled by funding rounds and expansions, with companies like Osteotech receiving significant investments to drive innovation and growth in the Resorbable Bone Substitute market.